Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 28, 2012	Sep. 30, 2011
Operating Activities
Net (loss) income	$ (15,829)	$ 43,105
Depreciation and amortization	36,128	37,134
Provisions for inventory obsolescence	5,351	5,705
Equity-based compensation	19,289	23,404
Tax effect of equity-based awards		188
Excess tax benefit received on exercise of equity-based awards	(2)	(305)
Gain on disposal of property and equipment	(95)	(28)
Settlement of interest rate swap		(2,965)
Loss on extinguishment of debt		8,399
Deferred income taxes	10,331	4,069
Changes in operating assets and liabilities
Trade receivables	1,797	20,249
Inventories	10,915	(7,200)
Prepaid expenses and other current assets	1,759	3,795
Trade payables and accrued liabilities	(8,127)	(14,810)
Income taxes	(48,344)	(643)
Other, net	(776)	(11,646)
Net cash flows from operating activities	12,397	108,451
Investing Activities
Proceeds from short-term investments	26,500
Purchases of short-term investments		(26,529)
Proceeds from long-term investments		10,110
Purchases of long-term investments		(7,253)
Proceeds from sales of property, plant and equipment	180	36
Purchase of property, plant and equipment	(5,665)	(8,770)
Net cash flows from investing activities	21,015	(32,406)
Financing Activities
Proceeds from exercise of equity-based awards	4,086	3,970
Excess tax benefit received from exercise of equity-based awards	2	305
Proceeds from long-term debt		278,195
Repayments of long-term debt	(50,000)	(298,500)
Payment of credit facility fees	(856)	(3,167)
Dividends paid	(46,818)	(46,163)
Repurchase of common stock	(6,398)
Net cash flows from financing activities	(99,984)	(65,360)
Effect of exchange rates on cash and cash equivalents	(11)	623
Net change in cash and cash equivalents	(66,583)	11,308
Cash and cash equivalents at the beginning of the period	383,693
Cash and cash equivalents at the end of the period	$ 317,110	$ 394,324